Feb 23, 2021
Ampio Brings New Hospitals Online in Trial for Inhalation Treatment of COVID-19 with Ampion
Feb 01, 2021
Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress
Jan 04, 2021
Ampio Provides Update on Clinical Trials for Ampion(TM) Treatment of COVID-19 Patients
Dec 29, 2020
Ampio Receives feedback from the FDA on Ampio's Proposed Modifications to the special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee
Dec 10, 2020
Ampio Enters into Collaborative Research Agreements to Explore Additional Clinical Indications for its Immunomodulatory Drug, Ampion
Dec 08, 2020
Ampio Pharmaceuticals, Inc. to Host its Annual Meeting on December 12, 2020
Nov 17, 2020
Ampio's Phase I Study for Inhaled Ampion Advances to 3rd Group of COVID-19 Patients with Respiratory Distress
Nov 10, 2020
Ampio's Phase I Study For Inhaled Ampion Advances To 2nd Group Of COVID-19 Patients With Respiratory Distress
Nov 02, 2020
Ampio Pharmaceuticals, Inc. to Host Conference Call on November 5th
Oct 28, 2020
Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress
Oct 27, 2020
Ampio Pharmaceuticals, Inc. to Present at the ROTH Capital Healthcare Event "COVID-19 Therapeutics in Development"
Oct 26, 2020
Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities
Sep 21, 2020
FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress
May 11, 2020
Ampio Reports Acceptance of Publication on the Potential Benefits of Nebulized Ampion(TM) for COVID-19 Patients
Apr 02, 2020
Ampio Pharmaceutical's Application to the FDA for a Clinical Study of Ampion(TM) to Treat COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS) featured in FOX News (VIDEO)
Feb 21, 2020
Ampio Provides Corporate Update
Dec 04, 2019
Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number
Oct 10, 2019
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility
Sep 18, 2019
Ampio Retains Legal Counsel for Transaction Advisory Committee
Sep 17, 2019
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial